C. Colletta

888 total citations
23 papers, 653 citations indexed

About

C. Colletta is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, C. Colletta has authored 23 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 19 papers in Epidemiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in C. Colletta's work include Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (16 papers) and Hepatitis B Virus Studies (7 papers). C. Colletta is often cited by papers focused on Liver Disease Diagnosis and Treatment (18 papers), Hepatitis C virus research (16 papers) and Hepatitis B Virus Studies (7 papers). C. Colletta collaborates with scholars based in Italy, United States and Australia. C. Colletta's co-authors include Pierluigi Toniutto, Mario Pirisi, Rosalba Minisini, Carlo Smirne, Carlo Fabris, Rachele Rapetti, Patrick S. Kamath, Roberto Giulio Romanelli, Lorenzo Ridola and Manuela Merli and has published in prestigious journals such as Hepatology, Journal of Hepatology and The American Journal of Gastroenterology.

In The Last Decade

C. Colletta

23 papers receiving 639 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Colletta Italy	11	549	524	155	57	52	23	653
Carine Chagneau-Derrode France	8	348 0.6×	331 0.6×	268 1.7×	12 0.2×	16 0.3×	14	457
Maciej Adler Belgium	8	182 0.3×	197 0.4×	127 0.8×	21 0.4×	26 0.5×	16	307
F Feu Spain	8	328 0.6×	358 0.7×	199 1.3×	27 0.5×	20 0.4×	17	467
Masumasa Horisawa Japan	9	330 0.6×	291 0.6×	215 1.4×	16 0.3×	51 1.0×	20	442
Tamás Tornai Hungary	12	211 0.4×	207 0.4×	79 0.5×	13 0.2×	28 0.5×	26	344
Jessica Wisocky United States	7	326 0.6×	235 0.4×	39 0.3×	28 0.5×	17 0.3×	8	456
Angeles Baquerizo United States	9	415 0.8×	248 0.5×	354 2.3×	15 0.3×	68 1.3×	21	608
Elizabeth Coss United States	7	241 0.4×	196 0.4×	501 3.2×	12 0.2×	103 2.0×	15	674
E. Otero Spain	13	224 0.4×	221 0.4×	177 1.1×	7 0.1×	17 0.3×	31	485
N. Sansonetti France	5	168 0.3×	258 0.5×	81 0.5×	21 0.4×	11 0.2×	10	461

Countries citing papers authored by C. Colletta

Since Specialization

Citations

This map shows the geographic impact of C. Colletta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Colletta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Colletta more than expected).

Fields of papers citing papers by C. Colletta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Colletta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Colletta. The network helps show where C. Colletta may publish in the future.

Co-authorship network of co-authors of C. Colletta

This figure shows the co-authorship network connecting the top 25 collaborators of C. Colletta. A scholar is included among the top collaborators of C. Colletta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Colletta. C. Colletta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Colletta, Alessandro, et al.. (2025). Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic liver disease and type 2 diabetes. Frontiers in Endocrinology. 16. 1531295–1531295. 1 indexed citations

Smirne, Carlo, Roberto G. Carbone, C. Colletta, et al.. (2022). Efficacy and Safety of Sofosbuvir and Ribavirin in an Italian Cohort of HCV Genotype 2 Elderly Cirrhotic Patients. Eurasian Journal of Medicine. 54(2). 113–120. 3 indexed citations

Colletta, C., et al.. (2020). Lifestyle and silymarin: a fight against liver damage in NAFLD associated - prediabetic disease. Journal of Diabetes & Metabolic Disorders. 19(2). 883–894. 9 indexed citations

Bellan, Mattia, C. Colletta, Livia Salmi, et al.. (2019). Severity of Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Mellitus: Relationship between Nongenetic Factors and PNPLA3/HSD17B13 Polymorphisms. Diabetes & Metabolism Journal. 43(5). 700–700. 20 indexed citations

Cavallin, M., Patrick S. Kamath, Manuela Merli, et al.. (2015). Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial. Hepatology. 62(2). 567–574. 227 indexed citations

Fabris, Carlo, Edmondo Falleti, Annarosa Cussigh, et al.. (2012). The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. Journal of Medical Virology. 84(5). 747–755. 12 indexed citations

Burlone, Michela Emma, Angelo Rossini, Andrea Magrì, et al.. (2012). A composite score including BMI liver stiffness and rs738409 PNPLA3 genotype might spare liver biopsies to most NAFLD patients maintaining 95% diagnostic accuracy. 2 indexed citations

Cavallin, M., Manuela Merli, Silvano Fasolato, et al.. (2012). 667 TERLIPRESSIN AND ALBUMIN VS MIDODRINE PLUS OCTREOTIDE AND ALBUMIN IN THE TREATMENT OF HRS IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL TRIAL BY AISF. Journal of Hepatology. 56. S264–S264. 1 indexed citations

Cavallin, M., Manuela Merli, Silvano Fasolato, et al.. (2012). OC-29 Terlipressin and albumin vs midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by A.I.S.F.. Digestive and Liver Disease. 44. S10–S10. 3 indexed citations

10.

Fabris, Carlo, C. Vandelli, Pierluigi Toniutto, et al.. (2010). Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. Journal of Gastroenterology and Hepatology. 26(2). 328–333. 16 indexed citations

11.

Falleti, Edmondo, Carlo Fabris, C. Vandelli, et al.. (2010). Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C. Human Immunology. 71(10). 999–1004. 33 indexed citations

12.

Fabris, Carlo, Carlo Smirne, Pierluigi Toniutto, et al.. (2008). Usefulness of six non-proprietary indirect markers of liver fibrosis in patients with chronic hepatitis C. Clinical Chemistry and Laboratory Medicine (CCLM). 46(2). 253–9. 10 indexed citations

13.

Ciancio, Alessia, Antonina Smedile, Chiara Giordanino, et al.. (2006). Long-Term Follow-Up of Previous Hepatitis C Virus Positive Nonresponders to Interferon Monotherapy Successfully Retreated with Combination Therapy: Are They Really Cured?. The American Journal of Gastroenterology. 101(8). 1811–1816. 16 indexed citations

14.

Fabris, Carlo, Carlo Smirne, Pierluigi Toniutto, et al.. (2006). Assessment of liver fibrosis progression in patients with chronic hepatitis C and normal alanine aminotransferase values: The role of AST to the platelet ratio index. Clinical Biochemistry. 39(4). 339–343. 29 indexed citations

15.

Ciancio, Angela, A. Smedile, Chiara Giordanino, et al.. (2006). P.255 Long term follow-up of previous hepatitis C virus positive non-responders to interferon monotherapy successfully re-treated with combination therapy: are they really cured?. Journal of Clinical Virology. 36. S141–S141. 1 indexed citations

16.

Colletta, C., Carlo Smirne, Carlo Fabris, et al.. (2005). Value of Two Noninvasive Methods to Detect Progression of Fibrosis Among HCV Carriers With Normal Aminotransferases *. Hepatology. 42(4). 838–845. 169 indexed citations

17.

Saracco, Giorgio Maria, Alessia Ciancio, Antonina Smedile, et al.. (2001). A Randomized 4–Arm Multicenter Study of Interferon Alfa-2B Plus Ribavirin in the Treatment of Patients With Chronic Hepatitis C Not Responding to Interferon Alone. Hepatology. 34(1). 133–138. 44 indexed citations

18.

Saracco, Giorgio Maria, Alessia Ciancio, Antonella Olivero, et al.. (2001). A randomised 4-arm multicentre study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C not responding to interferon alone. Journal of Hepatology. 34. 3–3. 3 indexed citations

19.

Pontisso, Patrizia, Giulia Morsica, Mariagrazia Ruvoletto, et al.. (1991). Hepatitis B virus binds to peripheral blood mononuclear cells via the pre S1 protein. Journal of Hepatology. 12(2). 203–206. 31 indexed citations

20.

Albertí, A., Liliana Chemello, Giovanna Fattovich, et al.. (1989). Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Digestive Diseases and Sciences. 34(10). 1559–1563. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact